EP3089741
Lyfjafræðilegar samsetningar sem innihalda AZD9291
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.1.2015EP published:
10.3.2021EP application number:
15700082.9
EP translation filed:
31.5.2021Grant published:
15.6.2021EPO information:
European Patent Register
Max expiry date:
1.1.2035Expiry date:
1.1.2027Next due date:
31.1.2027
Title:
PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291
Timeline
Today
2.1.2015EP application
10.3.2021EP Publication
31.5.2021Translation submitted
15.6.2021Registration published
1.1.2027Expires
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
WILSON, DavidAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
FINNIE, CindyAddress:
Macclesfield Cheshire SK10 2NA, GB
Name:
RAW, Steven AnthonyAddress:
Macclesfield Cheshire SK10 2NA, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201400034Date:
2.1.2014Country:
GB
Classification
Categories:
A61K 9/20, A61K 31/506, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 5.1.2022
Expires: 1.1.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.12.2022
Expires: 1.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.12.2023
Expires: 1.1.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 27.12.2024
Expires: 1.1.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 7.1.2026
Expires: 1.1.2027
Payer: Árnason Faktor ehf.